These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4021227)

  • 1. Modification of antinociceptive action of morphine by dopamine agonist and antagonist in mice.
    Kamata K; Ogawa K; Kameyama T
    Jpn J Pharmacol; 1985 May; 38(1):113-5. PubMed ID: 4021227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing effect of apomorphine on antinociceptive activity of morphine: a dose-dependent phenomenon.
    Gupta YK; Chugh A; Seth SD
    Pain; 1989 Feb; 36(2):263-269. PubMed ID: 2919107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of apomorphine on morphine analgesia during the state of dopaminergic supersensitivity after chronic treatment with haloperidol.
    Kamata K; Ogawa K; Noma S; Kameyama T
    J Pharmacobiodyn; 1986 Jan; 9(1):88-94. PubMed ID: 3712211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of dopaminergic stimulation and blockade on the nociceptive and antinociceptive responses of mice.
    Tulunay FC; Sparber SB; Takemori AE
    Eur J Pharmacol; 1975 Aug; 33(1):65-70. PubMed ID: 1175692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morphine may mimic the apomorphine cue by inhibiting dopaminergic autoinhibition.
    Hernandez LL; Holohean AM; Appel JB
    Eur J Pharmacol; 1982 Mar; 78(3):287-94. PubMed ID: 7067729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dopamine receptors in gastrointestinal motility.
    Dhasmana KM; Banerjee AK; Zhu YN; Erdmann W; Parmar SS; Salzman SK
    Res Commun Chem Pathol Pharmacol; 1989 Jun; 64(3):485-8. PubMed ID: 2571179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of mu-opioid receptors in potentiation of apomorphine-induced climbing behavior by morphine: studies using mu-opioid receptor gene knockout mice.
    Jang C; Park Y; Tanaka S; Ma T; Loh HH; Ho IK
    Brain Res Mol Brain Res; 2000 May; 78(1-2):204-6. PubMed ID: 10891603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations in the effects of dopamine agonists and antagonists on general activity in rats following chronic morphine treatment.
    Smee ML; Overstreet DH
    Psychopharmacology (Berl); 1976 Sep; 49(2):125-30. PubMed ID: 825898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of quipazine, fenfluramine and apomorphine on the morphine potentiation of tonic immobility.
    Wallnau LB
    Pharmacol Biochem Behav; 1981 Dec; 15(6):895-901. PubMed ID: 7323114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing influences of D-1 and D-2 dopamine receptors activation on morphine-induced antinociception.
    Zarrindast MR; Moghaddampour E
    Arch Int Pharmacodyn Ther; 1989; 300():37-50. PubMed ID: 2619426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition by MK-801 of morphine-induced conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice.
    Kim HS; Jang CG; Park WK
    Pharmacol Biochem Behav; 1996 Sep; 55(1):11-7. PubMed ID: 8870032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha 2-adrenoceptor- and D2-dopamine receptor-mediated analgesic response of B-HT 920.
    Verma A; Kulkarni SK
    J Pharm Pharmacol; 1991 Feb; 43(2):131-3. PubMed ID: 1672900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic ascorbate potentiates the effects of chronic haloperidol on behavioral supersensitivity but not D2 dopamine receptor binding.
    Pierce RC; Rowlett JK; Bardo MT; Rebec GV
    Neuroscience; 1991; 45(2):373-8. PubMed ID: 1762684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of repeated haloperidol and apomorphine administration on the development of tolerance for catalepsy and dopamine receptor hypersensitivity in mice].
    Zharkovskiĭ AM; Matvienko OA; Nurk AM
    Biull Eksp Biol Med; 1984 Oct; 98(10):444-6. PubMed ID: 6541951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic and cholinergic influences on morphine self-administration in rats.
    Glick SD; Cox RD
    Res Commun Chem Pathol Pharmacol; 1975 Sep; 12(1):17-24. PubMed ID: 1188183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of atrial natriuretic peptide on apomorphine-induced stereotyped cage-climbing behavior in mice.
    Bidzseranova A; Gueron J; Tóth G; Penke B; Telegdy G
    Eur J Pharmacol; 1992 Feb; 211(3):411-4. PubMed ID: 1352255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine.
    Yamawaki S; Lai H; Horita A
    J Pharmacol Exp Ther; 1983 Nov; 227(2):383-8. PubMed ID: 6631720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Further evidence that a single dose of an opiate can increase dopamine receptor sensitivity in mice.
    Martin JR; Takemori AE
    Eur J Pharmacol; 1987 Mar; 135(2):203-9. PubMed ID: 3582494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of D1 and D2 antagonists on basal and apomorphine decreased body temperature in mice and rats.
    Chipkin RE
    Pharmacol Biochem Behav; 1988 Jul; 30(3):683-6. PubMed ID: 2974995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic influence on withdrawal jumping behavior in morphine-dependent mice.
    Tseng LF; Brase DA; Loh HH
    Res Commun Chem Pathol Pharmacol; 1976 Nov; 15(3):435-46. PubMed ID: 1033590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.